“Comparison of Stem Cell Mobilization Efficacy with Intermediate Dose Cytarabine Versus Cyclophosphamide or Plerixafor in Poor Mobilizers” (2024) Voprosy onkologii, 70(4), pp. 727–732. doi:10.37469/0507-3758-2024-70-4-727-732.